LEADER 02738nam 2200637 450 001 9910814101803321 005 20210628203229.0 010 $a1-78063-375-0 035 $a(CKB)2670000000240530 035 $a(EBL)1574993 035 $a(OCoLC)865332725 035 $a(SSID)ssj0000767642 035 $a(PQKBManifestationID)11419315 035 $a(PQKBTitleCode)TC0000767642 035 $a(PQKBWorkID)10741311 035 $a(PQKB)10646250 035 $a(MiAaPQ)EBC1574993 035 $a(CaSebORM)9781843347095 035 $a(Au-PeEL)EBL1574993 035 $a(CaPaEBR)ebr10815597 035 $a(CaONFJC)MIL548924 035 $a(PPN)198678843 035 $a(EXLCZ)992670000000240530 100 $a20131219d2012 uy| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aFrom science 2.0 to pharma 3.0 $esemantic search and social media in the pharmaceutical industry and STM publishing /$fHerve? Basset, David Stuart and Denise Silber ; with contributions from Franc?ois Boutin 205 $a1st edition 210 1$aOxford :$cChandos Publishing,$d2012. 215 $a1 online resource (293 p.) 225 1 $aChandos publishing social media series 300 $aDescription based upon print version of record. 311 $a1-84334-709-1 320 $aIncludes bibliographical references and index. 327 $apart 1. From science 2.0 (2000-2010) -- part 2. ... and pharma 2.0 ... -- part 3. ... to pharma 3.0 (2010-). 330 $aScience 2.0 uses the resources of Web 2.0 to communicate between scientists, and with the general public. Web 3.0, in turn, has brought disruptive technologies such as semantic search, cloud computing and mobile applications into play. The term Pharma 3.0 anticipates the future relationship between drug makers and doctors with their patients in light of such technology. From Science 2.0 to Pharma 3.0 examines these developments, discussing the best and worst of Web 2.0 in science communication and health. Successes such as the Open Access phenomena and also less successful networks are covered 410 0$aChandos social media series. 606 $aOnline social network 606 $aPharmaceutical industry 615 0$aOnline social network. 615 0$aPharmaceutical industry. 676 $a501.3 700 $aBasset$b Herve?$01699145 701 $aStuart$b David$g(David Patrick)$0947363 701 $aSilber$b Denise$01699146 701 $aBoutin$b Franc?ois$01699147 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910814101803321 996 $aFrom science 2.0 to pharma 3.0$94081169 997 $aUNINA